Market Chameleon (Mon, 28-Sep 11:00 AM)
SCYNEXIS Lands BARDA Contract With Up to $214 Million to Advance SCY-247 Into Phase 2
Market Chameleon (Mon, 28-Sep 7:53 AM)
SCYNEXIS Adds Kidney-Disease R&D Leader Steven K. Burke to Board as SCY-770 Nears Phase 2
Market Chameleon (Tue, 22-Sep 11:51 AM)
